Poly-β-Cyclodextrin as a Superior Host for Gemcitabine
Gemcitabine remains a vital chemotherapeutic agent, yet its rapid deamination and short systemic persistence necessitate improved delivery strategies. This study
Nanoaggregation on command
ScienceDaily reported on the effect of cyclodextrins as parts of synthetic receptors on the aggregation of proteins, recently published by
Annual National Niemann Pick Disease Foundation Conference
Among several lectures useful for the families with member(s) suffering in rare diseases the ongoing clinical trials for NPC patients